ArticleBlood advances2021
Gupta V, Kennedy JA, Capo-Chichi J-M, et al. Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phase. Blood Adv. 2020;4(21):5562-5573.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.